Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides

Annals of the New York Academy of Sciences
Shiva ReddyJessica Astrid Rodrigues

Abstract

The precise fate of beta cells and the presence of islet infiltrates after onset of type 1 diabetes have not yet been fully characterized. Recently we showed that in newly diabetic NOD mice an appreciable number of beta cells remain. This was also observed during the first 2 weeks of diabetes in NOD mice without treatment with insulin. However, the mean number of beta cells per unit islet cross-sectional area decreased with increasing duration of disease. In contrast, glucagon and somatostatin cell numbers showed an increase. The persistence of insulitis in several islets until 4 weeks of diabetes suggests ongoing beta cell autoimmunity over a protracted phase. Combined daily treatment of newly diabetic NOD mice with epidermal growth factor (EGF) and gastrin for the first 14 days of diabetes resulted in temporary restoration of normoglycemia in 7 of 15 mice. We speculate that the residual beta cells present soon after onset of diabetes may respond to experimental regeneration. Treatment of newly diabetic NOD mice with the bioactive peptides EGF and gastrin resulted in partial and temporary reversal of diabetes. We propose that peptide therapies combined with other benign immunomodulatory approaches to rescue and preserve beta c...Continue Reading

References

Mar 23, 1999·Archives of Disease in Childhood·B J MuhammadJ L Botha
May 1, 2001·Journal of Pediatric Endocrinology & Metabolism : JPEM·E BöberA Büyükgebiz
Dec 28, 2002·Diabetes·Alexandra E ButlerPeter C Butler
Apr 29, 2006·Biochemical and Biophysical Research Communications·Zandong YangJerry L Nadler
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Francesco DottaPiero Marchetti
Mar 23, 2007·Annals of the New York Academy of Sciences·Vitaly AblamunitsKevan C Herold
Oct 24, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Peter C ButlerAnil Bhushan

❮ Previous
Next ❯

Citations

Oct 14, 2009·The Journal of Experimental Medicine·Francesca FallarinoRiccardo Calafiore
Jan 21, 2011·Physiological Reviews·Tom L van BelleMatthias G von Herrath

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.